Advertisement
Screener

Evolutionary Genomics, Inc. Amortization

Evolutionary Genomics, Inc. Amortization

Evolutionary Genomics, Inc. reported Amortization of $371.25 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.

Discontinued › Cash Flow › Operating Activities

us-gaap:AdjustmentForAmortization · last filed 2021-03-31

  • Evolutionary Genomics, Inc. amortization for the quarter ending 2020-12-31 was $333.05K, a 51138.00% increase year-over-year.
  • Evolutionary Genomics, Inc. amortization for the quarter ending 2020-09-30 was $36.90K, a 5568.20% increase year-over-year.
  • Evolutionary Genomics, Inc. amortization for the quarter ending 2019-12-31 was $650.00.
  • Evolutionary Genomics, Inc. amortization for the quarter ending 2019-09-30 was $651.00.
  • Evolutionary Genomics, Inc. amortization for fiscal 2020 was $371.25K, a 14167.79% increase from fiscal 2019.
  • Evolutionary Genomics, Inc. amortization for fiscal 2019 was $2.60K.
Period endAmortization 3 monthAmortization 6 monthAmortization 9 monthAmortization 12 month
2020-12-31$333.05K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
$369.95K
derived: sum of 2 quarters · filed 2021-03-31
$371.25K
10-K · filed 2021-03-31
2020-09-30$36.90K
10-Q · filed 2020-11-13
$38.20K
10-Q · filed 2020-11-13
2019-12-31$650.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
$1.30K
derived: sum of 2 quarters · filed 2021-03-31
$2.60K
10-K · filed 2021-03-31
2019-09-30$651.00
10-Q · filed 2020-11-13
$1.95K
10-Q · filed 2020-11-13